This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Opexa Therapeutics Inc.
OPXA : NASDAQ : Health Care

$1.49 | %
Today's Range: 1.46 - 1.57
Avg. Daily Volume: 625,200
04/17/14 - 3:59 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
OPXA OPEXA THERAPEUTICS INC 1.71 13.80 n/m 0.22 n/a
OXGN OXIGENE INC 3.33 7.57 n/m 0.04 -63.16
GNVC GENVEC INC 0.40 5.18 n/m 7.40 -52.66
IBIO IBIO INC 0.44 24.66 n/m 1.15 3.71
PTN PALATIN TECHNOLOGIES INC 0.61 23.88 n/m 0.02 -90.42
ISR ISORAY INC 0.69 23.88 n/m 4.66 -8.75
SNGX SOLIGENIX INC 1.54 18.84 n/m 3.40 -54.71
DARA DARA BIOSCIENCES INC 0.69 17.25 n/m 0.05 n/a
TZYM TRANZYME INC 0.58 16.01 n/m 6.44 -38.31
ICCC IMMUCELL CORP 3.70 11.17 92.50 5.52 4.70
CXM CARDIUM THERAPEUTICS INC 0.09 11.01 n/m 1.36 6720.00
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

OPXA Ind Avg S&P 500
n/m 32.90 18.96
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs